30 results on '"Yuan RY"'
Search Results
2. Spatial omics techniques and data analysis for cancer immunotherapy applications.
- Author
-
Zhang Y, Lee RY, Tan CW, Guo X, Yim WW, Lim JC, Wee FY, Yang WU, Kharbanda M, Lee JJ, Ngo NT, Leow WQ, Loo LH, Lim TK, Sobota RM, Lau MC, Davis MJ, and Yeong J
- Subjects
- Humans, Genomics methods, Tumor Microenvironment, Proteomics methods, Data Analysis, Neoplasms therapy, Neoplasms genetics, Immunotherapy methods
- Abstract
In-depth profiling of cancer cells/tissues is expanding our understanding of the genomic, epigenomic, transcriptomic, and proteomic landscape of cancer. However, the complexity of the cancer microenvironment, particularly its immune regulation, has made it difficult to exploit the potential of cancer immunotherapy. High-throughput spatial omics technologies and analysis pipelines have emerged as powerful tools for tackling this challenge. As a result, a potential revolution in cancer diagnosis, prognosis, and treatment is on the horizon. In this review, we discuss the technological advances in spatial profiling of cancer around and beyond the central dogma to harness the full benefits of immunotherapy. We also discuss the promise and challenges of spatial data analysis and interpretation and provide an outlook for the future., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier Ltd. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
3. Management of duodenal foreign bodies using the novel combined laparoscopic and endoscopic approaches in two unique cases.
- Author
-
Wang FT, Gao RY, Wu TQ, and Chen CQ
- Subjects
- Humans, Treatment Outcome, Duodenum surgery, Foreign Bodies surgery, Foreign Bodies diagnostic imaging, Laparoscopy methods
- Abstract
Competing Interests: Declaration of competing interest The authors declare that there are no competing interests.
- Published
- 2024
- Full Text
- View/download PDF
4. Phosphorus recovery from phosphate tailings through a two-stage leaching-precipitation process: Toward the harmless and reduction treatment of P-bearing wastes.
- Author
-
Yu YH, Du CM, Zhang YT, and Yuan RY
- Subjects
- Quartz, Apatites, Phosphorus, Phosphates chemistry, Calcium Carbonate, Magnesium
- Abstract
To achieve highly efficient extraction of phosphorus (P) and comprehensive utilization of phosphate tailings, a two-stage leaching-precipitation method was proposed. Phosphate tailings primarily consisted of dolomite, fluorapatite, and quartz. During the first-stage leaching, the large majority of dolomite was selectively dissolved and the leaching efficiency of Mg reached 93.1 % at pH 2.0 and 60 °C. The subsequent second-stage leaching of fluorapatite was performed and the P leaching efficiency was 98.8 % at pH 1.5 and 20 °C, while the quartz remained in the residue. Through two-stage leaching, a stepwise leaching of dolomite and fluorapatite was achieved. After chemical precipitation, calcium phosphate with a high purity of 97.9 % was obtained; and the total recovery efficiency of P exceeded 98 %. The obtained calcium phosphate can be a raw material in the phosphorus chemical industry, while the Mg-rich leachate and the final quartz-rich residue have the potential for Mg extraction and the production of mortars or geopolymers, respectively. The two-stage leaching-precipitation process could significantly reduce the leaching costs, and enhance the reaction rates. It is expected to realize a volume reduction and efficient resource utilization of the phosphate tailings by using this sustainable and promising solution., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
5. Geniposide improves depression-like behavior in prenatal stress male offspring through restoring HPA axis- and glucocorticoid receptor-associated dysfunction.
- Author
-
Ma Y, Li SX, Zhou RY, Deng LJ, le He W, Guo LL, Wang L, Hao JH, Li Y, Fang MF, and Cao YJ
- Subjects
- Female, Pregnancy, Male, Mice, Animals, Humans, Receptors, Glucocorticoid metabolism, Hypothalamo-Hypophyseal System metabolism, Stress, Psychological complications, Stress, Psychological drug therapy, Stress, Psychological metabolism, Pituitary-Adrenal System metabolism, Antidepressive Agents pharmacology, Antidepressive Agents therapeutic use, Antidepressive Agents metabolism, Hippocampus metabolism, Corticosterone metabolism, Depression drug therapy, Depression etiology, Depression metabolism, Prenatal Exposure Delayed Effects metabolism, Iridoids
- Abstract
Aims: Prenatal stress (PS) has an important impact on the brain development of offspring, which can lead to attention deficits, anxiety and depression in offspring. Geniposide (GE) is a kind of iridoid glycoside extracted from Gardenia jasminoides Ellis. It has various pharmacological effects and has been proved that have antidepressant effects. The aim of this study was to investigate the effect of GE on depression-like behavior in PS-induced male offspring mice and explore the possible molecular mechanisms., Methods: We used a prenatal restraint stress model, focusing on male PS-induced offspring mice to study the effects of GE., Key Findings: The results showed that GE administration for 4 weeks significantly improved the depression-like behavior in PS offspring mice, which was manifested by markedly increasing the sucrose preference of PS offspring and the activity in the open field test, and reducing the immobility time in the forced swimming test. In addition, GE significantly reduced the levels of hypothalamic-pituitary-adrenal (HPA) axis-related hormones and exceedingly increased the protein expression of MAP2 and GAP43 in PS offspring. Furthermore, GE increased Glucocorticoid receptors (GR) nuclear translocation in the hippocampus of PS offspring, and enhanced the expression of synaptic plasticity-related proteins., Conclusion: The results of this study showed that GE exerts antidepressant effects in male PS offspring mice by regulating the HPA axis, GR function and proteins related to synaptic plasticity., Competing Interests: Declaration of competing interest The authors have no conflict of interest to declare., (Copyright © 2024 Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
6. Nao Tan Qing ameliorates Alzheimer's disease-like pathology by regulating glycolipid metabolism and neuroinflammation: A network pharmacology analysis and biological validation.
- Author
-
Li Q, Jia C, Wu H, Liao Y, Yang K, Li S, Zhang J, Wang J, Li G, Guan F, Leung E, Yuan Z, Hua Q, and Pan RY
- Subjects
- Animals, Mice, Neuroinflammatory Diseases, Network Pharmacology, Mice, Transgenic, Disease Models, Animal, Lipid Metabolism, Glycolipids therapeutic use, Amyloid beta-Peptides metabolism, Alzheimer Disease metabolism
- Abstract
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by progressive cognitive decline and currently there are no available treatments. Alongside the conventional Aβ and tau hypotheses, neuroinflammation and metabolism disruption have also been regarded as crucial hallmarks of AD. In this study, a novel Chinese formula Nao Tan Qing (NTQ) was developed and shown to improve AD. In vivo experiments showed that NTQ significantly mitigated cognitive impairment, Aβ burden and neuroinflammation in a transgenic AD mouse model (5×FAD). Network pharmacology results revealed that the active components of NTQ could target inflammatory and metabolic pathways. In addition, hippocampal transcriptomics suggested that NTQ regulated signaling pathways related to inflammation and lipid metabolism. Consistently, serum metabolomics further indicated that NTQ could modulate glycolipid metabolism. In summary, a combination of systems pharmacology analysis and biological validation study demonstrates that NTQ could alleviate behavioral abnormality and pathological alterations of AD by targeting glycolipid metabolism and neuroinflammation, and is accordingly a potential therapeutic agent for AD., Competing Interests: Conflict of interest The authors declare no conflicts of interest., (Copyright © 2022 Elsevier Ltd. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
7. Omega-3 polyunsaturated fatty acid supplementation improves lipid metabolism and endothelial function by providing a beneficial eicosanoid-pattern in patients with acute myocardial infarction: A randomized, controlled trial.
- Author
-
Yuan M, Zhang Y, Hua T, Liu XL, Liu T, Yuan RY, Li GP, Zhu Y, and Zhang X
- Subjects
- Acute Disease, Aged, Atrial Fibrillation etiology, Atrial Fibrillation prevention & control, Death, Sudden, Cardiac prevention & control, Eicosanoids blood, Endothelium, Vascular physiopathology, Female, Humans, Intention to Treat Analysis, Leukotriene B4 blood, Male, Metabolome, Metabolomics, Middle Aged, Myocardial Infarction blood, Nitric Oxide biosynthesis, Nutrition Policy, Percutaneous Coronary Intervention, Prostaglandin D2 analogs & derivatives, Prostaglandin D2 blood, Dietary Supplements, Endothelium, Vascular drug effects, Fatty Acids, Omega-3 administration & dosage, Lipid Metabolism drug effects, Myocardial Infarction therapy
- Abstract
Background & Aims: Omega-3 polyunsaturated fatty acid (ω-3 PUFA) have been reported to have beneficial cardiovascular effects, but its mechanism of protection against acute myocardial infarction (AMI) who are under guideline-based therapy is not fully understood. Here, we used a metabolomic approach to systematically analyze the eicosanoid metabolites induced by ω-3 PUFA supplementation and investigated the underlying mechanisms., Methods: Participants with AMI after successful percutaneous coronary intervention were randomized to 3 months of 2 g daily ω-3 PUFA and guideline-adjusted therapy (n = 30, ω-3 therapy) or guideline-adjusted therapy alone (n = 30, Usual therapy). Functional PUFA-derived eicosanoids in plasma were profiled by metabolomics. Clinical and laboratory tests were obtained before and 3 months after baseline and after the study therapy., Results: By intent-to-treat analysis, the content of 11-HDoHE, 20-HDoHE and 16,17-EDP and that of epoxyeicosatetraenoic acids (EEQs), derived from docosahexaenoic acid and eicosapentaenoic acid, respectively, were significantly higher with ω-3 group than Usual therapy, whereas that of prostaglandin J2 (PGJ2) and leukotriene B4, derived from arachidonic acid, was significantly decreased. As compared with Usual therapy, ω-3 PUFA therapy significantly reduced levels of triglycerides (-6.3%, P < 0.05), apolipoprotein B (-4.9%, P < 0.05) and lipoprotein(a) (-37.0%, P < 0.05) and increased nitric oxide level (62.2%, P < 0.05). In addition, the levels of these variables were positively correlated with change in 16,17-EDP and EEQs content but negatively with change in PGJ2 content., Conclusions: ω-3 PUFA supplementation may improve lipid metabolism and endothelial function possibly by affecting eicosanoid metabolic status at a systemic level during convalescent healing after AMI., Clinical Trial Registration: URL: http://www.chictr.org.cn. Unique identifier: ChiCTR1900025859., Competing Interests: Conflict of interest None of the authors report a conflict of interest related to the study., (Copyright © 2020. Published by Elsevier Ltd.)
- Published
- 2021
- Full Text
- View/download PDF
8. Hormone levels are related to functional compensation in prolactinomas: A resting-state fMRI study.
- Author
-
Yao S, Lin P, Vera M, Akter F, Zhang RY, Zeng A, Golby AJ, Xu G, Tie Y, and Song J
- Subjects
- Brain diagnostic imaging, Female, Hormones, Humans, Magnetic Resonance Imaging, Male, Pituitary Neoplasms diagnostic imaging, Prolactinoma diagnostic imaging
- Abstract
Prolactinomas are tumors of the pituitary gland, which overproduces prolactin leading to dramatic fluctuations of endogenous hormone levels throughout the body. While it is not fully understood how endogenous hormone disorders affect a patient's brain, it is well known that fluctuating hormone levels can have negative neuropsychological effects. Using resting-state functional magnetic resonance imaging (rs-fMRI), we investigated whole-brain functional connectivity (FC) and its relationship with hormone levels in prolactinomas. By performing seed-based FC analyses, we compared FC metrics between 33 prolactinoma patients and 31 healthy controls matched for age, sex, and hand dominance. We then carried out a partial correlation analysis to examine the relationship between FC metrics and hormone levels. Compared to healthy controls, prolactinoma patients showed significantly increased thalamocortical and cerebellar-cerebral FC. Endogenous hormone levels were also positively correlated with increased FC metrics, and these hormone-FC relationships exhibited sex differences in prolactinoma patients. Our study is the first to reveal altered FC patterns in prolactinomas and to quantify the hormone-FC relationships. These results indicate the importance of endogenous hormones on functional compensation of the brain in patients with prolactinomas., Competing Interests: Declaration of Competing Interest The authors declare no conflicts of interest., (Copyright © 2020 Elsevier B.V. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
9. A novel SCNN1G mutation in a PHA I infant patient correlates with nephropathy.
- Author
-
Yin LP, Zhu H, Zhu RY, and Huang L
- Subjects
- Animals, Apoptosis, Epithelial Sodium Channels blood, Humans, Infant, Kidney Diseases blood, Kidney Diseases pathology, Pseudohypoaldosteronism blood, Rats, Epithelial Sodium Channels genetics, Kidney Diseases genetics, Mutation, Pseudohypoaldosteronism genetics
- Abstract
Systematic form of pseudohypoaldosteronism Type I (PHA I) is a rare recessive homozygous inherited syndrome characterized by severe salt loss, hyperkalemia, hyponatremia, metabolic acidosis, hyperaldosteronism and hyperreninemia. It is caused by mutations in one of the genes encoding the α, β and γ subunits of epithelial sodium channels (ENaC). In this study, we performed whole exome sequencing on an infant patient with PHA I as well as nephropathy. The result presented a novel homozygous six-base deletion in the γ subunit encoding gene SCNN1G. Then we correlated the mutant to kidney damage, along with transcriptional alterations of genes involved in inflammation, oxidative stress and apoptosis, via in vitro and in vivo tests. In addition, it was demonstrated that the SCNN1G defects triggered programmed cell death via inhibiting miR-21 and upregulating PTEN, which then orchestrated the key downstream regulators, including Bcl2, Bax2, and cleaved Caspse-3 in a way that favors cell apoptosis. The study enhances our understanding of the pathophysiology of the disorder of PHA I and the mechanisms of renal damage induced by the novel defect., (Copyright © 2019 Elsevier Inc. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
10. DJ-1 overexpression confers the multidrug resistance phenotype to SGC7901 cells by upregulating P-gp and Bcl-2.
- Author
-
Liu HY, Duan GL, Xu RY, Li XR, Xiao L, Zhao L, Ma ZX, Xu XW, Qiu LJ, Zhu ZM, and Chen HP
- Subjects
- Antineoplastic Agents pharmacology, Cell Cycle drug effects, Cell Proliferation drug effects, Drug Resistance, Neoplasm drug effects, Drug Screening Assays, Antitumor, Humans, Phenotype, Protein Deglycase DJ-1 antagonists & inhibitors, Protein Deglycase DJ-1 metabolism, Tumor Cells, Cultured, ATP Binding Cassette Transporter, Subfamily B metabolism, Drug Resistance, Neoplasm genetics, Protein Deglycase DJ-1 genetics, Proto-Oncogene Proteins c-bcl-2 metabolism, Up-Regulation drug effects
- Abstract
Gastric cancer (GC) is one of the most malignant tumors with high incidence and mortality worldwide, and the multidrug resistance (MDR) often results in chemotherapy failure in GC. DJ-1 has been well indicated to be associated with drug resistance in multiple cancers. However, the role of DJ-1 in the MDR of gastric cancer cells and its possible mechanism remain to be elucidated. Therefore, the current study was investigated whether DJ-1 expression is differential in parental gastric cancer cell SGC7901 and vincristine (VCR)-induced gastric cancer MDR cell SGC7901/VCR, and whether DJ-1 plays a significant role in development of MDR in gastric cancer. The results showed that DJ-1 expression in SGC7901/VCR cells was significantly higher than its sensitive parental SGC7901 cells. Furthermore, DJ-1 overexpressed gastric cancer cell line SGC7901/LV-DJ-1 led to the increase of cell survival rate, the IC
50 of chemotherapeutic drugs and number of cell clones as well as decrease of cell cycle G0/G1 phase ratio compared with its parental cells under the treatment of VCR, adriamycin (ADR), 5-Fluorouracil (5-FU) and cisplatin (DDP). However, the DJ-1 knockdown stable cell line SGC7901/VCR/shDJ-1 reversed the above mentioned series of MDR. Moreover, it was found that upregulation of DJ-1 protein expression promoted the pumping rate of GC cells to ADR and reduced the apoptotic index of GC cells treated with chemotherapeutic drugs by upregulating P-gp and Bcl-2. Similarly, knocking down DJ-1, P-gp or Bcl-2 displayed a converse effect. In conclusion, the current study demonstrated that DJ-1 overexpression confers the MDR phenotype to SGC7901 cells and this process is related to DJ-1 promoting active efflux of drugs and enhancing the anti-apoptotic ability of MDR GC cells by upregulating P-gp and Bcl-2., (Copyright © 2019 Elsevier Inc. All rights reserved.)- Published
- 2019
- Full Text
- View/download PDF
11. Resveratrol attenuates myocardial hypoxia/reoxygenation-induced cell apoptosis through DJ-1-mediated SIRT1-p53 pathway.
- Author
-
Xu RY, Xu XW, Deng YZ, Ma ZX, Li XR, Zhao L, Qiu LJ, Liu HY, and Chen HP
- Subjects
- Acetylation, Animals, Cell Line, Cell Survival, Enzyme Activation, L-Lactate Dehydrogenase metabolism, Protein Binding, Protein Deglycase DJ-1 biosynthesis, Rats, Tumor Suppressor Protein p53 chemistry, Apoptosis drug effects, Cardiotonic Agents pharmacology, Cell Hypoxia, Myocardial Ischemia pathology, Myocardial Reperfusion Injury prevention & control, Protein Deglycase DJ-1 metabolism, Resveratrol pharmacology, Sirtuin 1 metabolism, Tumor Suppressor Protein p53 metabolism
- Abstract
Resveratrol, a multi-functional phytoalexin, has been well indicated to exert cardioprotective effects by weakening ischemia/reperfusion (I/R) injury, and cell apoptosis is a vital way in I/R injury. SIRT1-p53 pathway has strong significance in regulating cell apoptosis. DJ-1 can directly bind to SIRT1 and stimulate the activity of SIRT1-p53. Therefore, the current study was determined whether Resveratrol attenuates hypoxia/reoxygenation (H/R)-induced cell apoptosis, and whether DJ-1-mediated SIRT1 activation involves in the cardioprotective effects of Resveratrol. The results showed that remarkable decrease in the number of apoptotic cells along with reduction of lactate dehydrogenase release and restoration of cell viability emerged when Resveratrol was applied in the H9c2 cells exposed to H/R. Moreover, Resveratrol increased DJ-1 expression and promoted the interaction of DJ-1 with SIRT1, which further contributed to subsequent restoration of SIRT1 activity and decrease of acetylation level of p53. However, above cardioprotective effects of Resveratrol were abrogated by DJ-1 siRNA and SIRT1 specific inhibitor Sirtinol. In conclusion, the current study demonstrated that Resveratrol suppressed H/R-induced cell apoptosis, which may be conducted by up-regulating DJ-1, and later activating SIRT1 activity and subsequently inhibiting p53 acetylation level in the H9c2 cells., (Copyright © 2019 Elsevier Inc. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
12. Impact of Virtual and Augmented Reality Based on Intraoperative Magnetic Resonance Imaging and Functional Neuronavigation in Glioma Surgery Involving Eloquent Areas.
- Author
-
Sun GC, Wang F, Chen XL, Yu XG, Ma XD, Zhou DB, Zhu RY, and Xu BN
- Subjects
- Adult, Aged, Female, Humans, Imaging, Three-Dimensional, Magnetic Resonance Imaging, Male, Middle Aged, Retrospective Studies, Statistics, Nonparametric, User-Computer Interface, Brain Neoplasms diagnostic imaging, Brain Neoplasms surgery, Glioma diagnostic imaging, Glioma surgery, Monitoring, Intraoperative methods, Neuronavigation methods
- Abstract
Background: The utility of virtual and augmented reality based on functional neuronavigation and intraoperative magnetic resonance imaging (MRI) for glioma surgery has not been previously investigated., Methods: The study population consisted of 79 glioma patients and 55 control subjects. Preoperatively, the lesion and related eloquent structures were visualized by diffusion tensor tractography and blood oxygen level-dependent functional MRI. Intraoperatively, microscope-based functional neuronavigation was used to integrate the reconstructed eloquent structure and the real head and brain, which enabled safe resection of the lesion. Intraoperative MRI was used to verify brain shift during the surgical process and provided quality control during surgery. The control group underwent surgery guided by anatomic neuronavigation., Results: Virtual and augmented reality protocols based on functional neuronavigation and intraoperative MRI provided useful information for performing tailored and optimized surgery. Complete resection was achieved in 55 of 79 (69.6%) glioma patients and 20 of 55 (36.4%) control subjects, with average resection rates of 95.2% ± 8.5% and 84.9% ± 15.7%, respectively. Both the complete resection rate and average extent of resection differed significantly between the 2 groups (P < 0.01). Postoperatively, the rate of preservation of neural functions (motor, visual field, and language) was lower in controls than in glioma patients at 2 weeks and 3 months (P < 0.01)., Conclusion: Combining virtual and augmented reality based on functional neuronavigation and intraoperative MRI can facilitate resection of gliomas involving eloquent areas., (Copyright © 2016 Elsevier Inc. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
13. Epicatechin isolated from Tripterygium wilfordii extract reduces tau-GFP-induced neurotoxicity in zebrafish embryo through the activation of Nrf2.
- Author
-
Wu BK, Yuan RY, Chang YP, Lien HW, Chen TS, Chien HC, Tong TS, Tsai HP, Fang CL, Liao YF, Chang CC, Chen RP, and Huang CJ
- Subjects
- Animals, Dose-Response Relationship, Drug, Embryo, Nonmammalian drug effects, Embryo, Nonmammalian metabolism, Embryo, Nonmammalian pathology, Green Fluorescent Proteins genetics, Green Fluorescent Proteins metabolism, Neurons drug effects, Neuroprotective Agents administration & dosage, Plant Extracts administration & dosage, Recombinant Fusion Proteins genetics, Recombinant Fusion Proteins metabolism, Zebrafish, tau Proteins genetics, Catechin administration & dosage, NF-E2-Related Factor 2 metabolism, Neurons metabolism, Neurons pathology, Tripterygium chemistry, Zebrafish Proteins metabolism, tau Proteins metabolism
- Abstract
Tau plays important roles in the assembly and stabilization of the microtubule structure to facilitate axonal transport in mammalian brain. The intracellular tau aggregates to form paired helical filaments leading to neurodegenerative disorders, collectively called tauopathies. In our previous report, we established a zebrafish model to express tau-GFP to induce neuronal death, which could be directly traced in vivo. Recently, we used this model to screen 400 herbal extracts and found 45 of them to be effective on reducing tau-GFP-induced neuronal death. One of the effective herbal extracts is the Tripterygium wilfordii stem extract. HPLC analysis and functional assay demonstrated that epicatechin (EC) is the major compound of Tripterygium wilfordii stem extract to decrease the neurotoxicity induced by tau-GFP. Using a luciferase reporter assay in the zebrafish, we confirmed that EC could activate Nrf2-dependent antioxidant responses to significantly increase the ARE-controlled expression of luciferase reporter gene. These data suggest that EC from the Tripterygium wilfordii stem extract could diminish tau-GFP-induced neuronal death through the activation of Nrf2., (Copyright © 2016 Elsevier Inc. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
14. Structure and preventive effects against ethanol-induced gastric ulcer of an expolysaccharide from Lachnum sp.
- Author
-
Xu P, Yang L, Yuan RY, Ye ZY, Ye HR, and Ye M
- Subjects
- Animals, Anti-Ulcer Agents isolation & purification, Female, Fungal Polysaccharides isolation & purification, Gastric Mucosa drug effects, Gastric Mucosa pathology, Glycosylation, Male, Methylation, Mice, Molecular Weight, Monosaccharides analysis, Stomach Ulcer chemically induced, Stomach Ulcer pathology, Anti-Ulcer Agents chemistry, Anti-Ulcer Agents pharmacology, Ascomycota chemistry, Ethanol adverse effects, Fungal Polysaccharides chemistry, Fungal Polysaccharides pharmacology, Stomach Ulcer prevention & control
- Abstract
An extracellular polysaccharide of Lachnum sp. (LEP) was purified by DEAE-cellulose 52 column chromatography and Sepharose CL-6B column chromatography. LEP-2a was identified to be a homogeneous component with an average molecular weight of 3.22 × 10(4)Da. The structure of LEP-2a was characterized by chemical and spectroscopic methods, including methylation analysis, periodate oxidation-smith degradation, infrared spectroscopy and NMR analysis. Results indicated that LEP-2a was a (1→3)-,(1→6)-β-D-Glcp, whose branch chain was consist of two d-glucopyranosyl residues linked by β-1,3-glycosidic linkage, which was linked at C6 of the backbone chain by β-1,6-glycosidic linkage. To study the protective effects of LEP-2a on the ethanol-induced gastric ulcer in mice, LEP-2a (100, 200 and 400mg/kg/d) was given to mice by gavage for 2 weeks. Results showed that LEP-2a significantly decreased the ulcer bleeding areas, pepsin activity, gastric juice volume, gastric juice total acidity and the malondialdehyde (MDA) content in serum. Meanwhile, the superoxide dismutase (SOD) increased significantly. The above findings suggested that LEP-2a had a significant preventive effect against the ethanol-induced gastric ulcer., (Copyright © 2016 Elsevier B.V. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
15. Molecular cloning and immune responsive expression of LGP2 gene, a pivotal member of the RLR gene family from Muscovy duck Cairina moschata.
- Author
-
Jiao PR, Wei LM, Song YF, Cui J, Zhang S, Han F, Yuan RY, and Liao M
- Subjects
- Amino Acid Sequence, Animals, Avian Proteins metabolism, Brain immunology, Brain metabolism, Cloning, Molecular, Ducks, Influenza in Birds virology, Lung immunology, Lung metabolism, Molecular Sequence Data, Organ Specificity, RNA, Messenger genetics, RNA, Messenger metabolism, Real-Time Polymerase Chain Reaction veterinary, Sequence Alignment veterinary, Spleen immunology, Spleen metabolism, Avian Proteins genetics, Immunity, Innate, Influenza A Virus, H5N1 Subtype physiology, Influenza in Birds genetics, Influenza in Birds immunology
- Abstract
Laboratory of genetics and physiology 2 (LGP2) is an important intracellular receptor that recognizes viral RNAs in innate immunity. In this study, a novel LGP2 cDNA was identified from the spleen of a Muscovy duck (Cairina moschata). The deduced amino acid sequence of Muscovy duck LGP2 (MDLGP2) consisted of 675 amino acid residues. The peptide contained two main structure domains: six important motifs, including a DExD/H box for RNA helicase activity in the RNA helicase region located at the N-terminal region, and two Zn2+-binding regions with an RNA-binding loop in the C-terminus regulatory domain (CTD). The MdLGP2 mRNA was ubiquitously expressed in the tested tissues, with high expression levels in glandular stomach, colon, ileum, crop, and caecum tissues, and low expression levels in the brain, skin, and heart. The mRNA expression of MdLGP2 was significantly upregulated in the brain, spleen, and lungs of ducks in the early stages of postinfection with H5N1 highly pathogenic avian influenza virus (HPAIV). These results suggested that MdLGP2 was involved in the early stages of antiviral innate immune response in ducks after infection with H5N1 HPAIV. However, whether it plays a positive or negative regulatory role in the host antiviral response requires further investigation., (© 2015 Poultry Science Association Inc.)
- Published
- 2015
- Full Text
- View/download PDF
16. Isolation and identification of phase I metabolites of phillyrin in rats.
- Author
-
Li C, Yao ZH, Qin ZF, Zhang JB, Cao RY, Dai Y, and Yao XS
- Subjects
- Administration, Oral, Animals, Antiviral Agents analysis, Glucosides administration & dosage, Male, Metabolic Detoxication, Phase I, Molecular Structure, Rats, Sprague-Dawley, Forsythia chemistry, Glucosides urine
- Abstract
Phillyrin was one of the main chemical constituents of the fruit of Forsythia suspensa (Thunb.) Vahl. It showed various bioactivities including antioxidant and anti-inflammatory activities. However, the metabolism of phillyrin remained unknown. This report described the isolation and identification of phase I metabolites of phillyrin in rats. Nine metabolites including six new ones were isolated by various column chromatographies and high-performance liquid chromatography. Their structures were elucidated by extensive spectroscopic analysis. The antiviral activities of phillyrin and the metabolites were evaluated against influenza A (H3N2) virus. Among them, one metabolite M8 showed moderate activity with the IC50 value of 26.39 μM, and three metabolites (M2, M3, M9) showed weak antiviral activities at the concentration of 100 μM. Based on the structures of the metabolites, possible metabolic pathways of phillyrin in rats were also proposed., (Copyright © 2014. Published by Elsevier B.V.)
- Published
- 2014
- Full Text
- View/download PDF
17. Rosai-Dorfman disease: a retrospective analysis of 13 cases.
- Author
-
Zhu F, Zhang JT, Xing XW, Wang DJ, Zhu RY, Zhang Q, Wang HT, and Lang SY
- Subjects
- Cerebellum metabolism, Cerebellum pathology, Female, Humans, Immunohistochemistry, Male, Middle Aged, Nasal Cavity metabolism, Nasal Cavity pathology, Paranasal Sinuses metabolism, Paranasal Sinuses pathology, Prognosis, Retrospective Studies, Spinal Cord metabolism, Spinal Cord pathology, Histiocytosis, Sinus metabolism, Histiocytosis, Sinus pathology
- Abstract
Background: Rosai-Dorfman disease (RDD) is a rare, idiopathic, histiocytic proliferative disorder, the infrequent occurrence of which limits in-depth studies. Consequently, many characteristics of this disease remain unknown, restricting early diagnosis and proper treatment., Methods: In this study, the literature was reviewed and a retrospective analysis of the medical records of 13 patients with RDD conducted to investigate the demographic data, clinical data, laboratory and imaging results, treatment, and prognosis of this disease., Results: Of the 13 cases in our sample, 10 (77%) were purely extranodal RDD, 2 (15%) were both nodal and extranodal, and 1 (8%) was purely nodal. The locations of the 10 purely extranodal RDD lesions included the central nervous system (n = 6, 60%), nasal cavity and paranasal sinuses (n = 3, 30%), and the cutis (n = 1, 10%). The locations of the central nervous system-related RDD lesions included the cerebral subdura (n = 2, 29%), the sellar region (n = 3, 14%), the cerebral parenchyma (n = 1, 14%) and the spinal subdura (n = 1, 14%). Ten patients (77%) had stable conditions, 3 (23%) experienced recurrence, and 2 (15%) experienced recurrence and lesion metastasis., Conclusions: RDD is rare, requiring knowledge of its clinical manifestations for a rapid and correct diagnosis. In light of the possibility of recurrence and lesion metastasis, long-term follow-up is needed. Treatment is still controversial. Future efforts should be directed at investigating the etiology and postoperative treatment for relapsing cases or those with subresected lesions.
- Published
- 2013
- Full Text
- View/download PDF
18. Molecular cloning, characterization, and expression analysis of the Muscovy duck Toll-like receptor 3 (MdTLR3) gene.
- Author
-
Jiao PR, Wei LM, Cheng YQ, Yuan RY, Han F, Liang J, Liu WL, Ren T, Xin CA, and Liao M
- Subjects
- Amino Acid Sequence, Animals, Ducks genetics, Influenza A Virus, H5N1 Subtype, Influenza in Birds metabolism, Influenza in Birds virology, Molecular Sequence Data, RNA, Messenger genetics, RNA, Messenger metabolism, Toll-Like Receptor 3 genetics, Cloning, Molecular, Ducks metabolism, Gene Expression Regulation physiology, Toll-Like Receptor 3 metabolism
- Abstract
Toll-like receptor 3 (TLR3) is an important membrane-bound receptor for recognizing double-stranded RNA in innate immunity. In this study, we described the cloning and characterization of the Muscovy duck TLR3 (MdTLR3) gene. The full-length MdTLR3 cDNA (2,836 bp) encoded a polypeptide of 895 amino acids. The deduced amino acid sequence contained 4 main structural domains: a signal peptide, an extracellular leucine rich repeats domain, a transmembrane domain, and a Toll/IL-1 receptor domain. Quantitative real-time PCR analysis indicated that MdTLR3 mRNA was constitutively expressed in all sampled tissues of uninfected Muscovy duck except muscle. Expression of MdTLR3 in brain was significantly upregulated at 24 h (1.94-fold, P < 0.05), reached a peak at 48 h (4.64-fold, P < 0.05), and recovered to normal levels at 72 h postinfection with the H5N1 highly pathogenic avian influenza virus. In contrast, MdTLR3 expression was downregulated during the test period in spleen and lung. These results implicated MdTLR3 was a novel member of the TLR family, which is involved in the early stage of antiviral innate immunity.
- Published
- 2012
- Full Text
- View/download PDF
19. Neurovascular protection conferred by 2-BFI treatment during rat cerebral ischemia.
- Author
-
Han Z, Cheng ZH, Liu S, Yang JL, Xiao MJ, Zheng RY, and Hou ST
- Subjects
- Animals, Brain Ischemia complications, Imidazoline Receptors metabolism, Infarction, Middle Cerebral Artery complications, Ligands, Male, Middle Cerebral Artery physiopathology, Rats, Rats, Sprague-Dawley, von Willebrand Factor metabolism, Benzofurans administration & dosage, Brain Ischemia drug therapy, Cerebrum blood supply, Cerebrum drug effects, Imidazoles administration & dosage, Infarction, Middle Cerebral Artery drug therapy, Middle Cerebral Artery drug effects, Neuroprotective Agents administration & dosage, Stroke prevention & control
- Abstract
Stroke is caused by vascular dysfunction and currently there are no effective therapeutics to stroke induced brain damage. In contrast to an intense emphasis on neuroprotection, relatively few studies have addressed means of vascular protection in cerebral ischemia. Here we discovered that the ligand to immidazolin receptor, 2-BFI, not only provided potent neuroprotection during middle cerebral artery occlusion in rat, which confirmed our previous reports, but also protected the integrity of the cerebral vasculature. Treatment with 2-BFI twice daily after the occlusion of the middle cerebral artery for 14 d significantly improved the neurological deficits, reduced brain infarction, and importantly, protected the cerebral vasculature as evidenced by the increased expression of an endothelial marker, von Willebrand factor, and better preservation of the cerebral vasculature, as viewed under a confocal microscope on rat brain perfused with FITC-labeled dextran. These results indicated that 2-BFI contributes to protection of neurovasculature. Understanding the molecular mechanisms could eventually lead to development of more effective therapies for stroke., (Crown Copyright © 2012. Published by Elsevier Inc. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
20. 2-BFI attenuates experimental autoimmune encephalomyelitis-induced spinal cord injury with enhanced B-CK, CaATPase, but reduced calpain activity.
- Author
-
Wang P, Wang ZW, Lin FH, Han Z, Hou ST, and Zheng RY
- Subjects
- Animals, Axons drug effects, Axons pathology, Calcium-Transporting ATPases biosynthesis, Calpain antagonists & inhibitors, Creatine Kinase, BB Form biosynthesis, Encephalomyelitis, Autoimmune, Experimental enzymology, Encephalomyelitis, Autoimmune, Experimental etiology, Encephalomyelitis, Autoimmune, Experimental pathology, Female, Mice, Mice, Inbred C57BL, Multiple Sclerosis enzymology, Spinal Cord Injuries complications, Spinal Cord Injuries enzymology, Benzofurans therapeutic use, Encephalomyelitis, Autoimmune, Experimental drug therapy, Imidazoles therapeutic use, Multiple Sclerosis drug therapy
- Abstract
The lack of disease-modifying pharmacological agents for effective treatment of multiple sclerosis (MS) still represents a large and urgent unmet medical need. Our previous studies showed that ligands to type 2 imidazoline receptors (I(2)R) were effective in protecting spinal cord injury caused by experimental autoimmune encephalomyelitis (EAE), a mouse model of MS. In this study, we further examined the protective property of a very selective ligand of I(2)R, 2-(2-benzofuranyl) 2-imidazoline (2-BFI) against EAE. Importantly, a mechanism of 2-BFI-mediated protection was investigated which possibly involves an I(2)R binding protein, brain-creatine kinase (B-CK), as well as CaATPase and calpain. The enzymatic activity of B-CK and CaATPase was significantly reduced in EAE injured spinal cord. Reduction of B-CK activity in EAE spinal cord may lead to energy reduction and dysfunction in cellular calcium homeostasis. Increased intracellular calcium evokes elevation of calpain activity occurring in EAE spinal cord which causes further tissue damage. Indeed, EAE injured spinal cord showed significant reduction in CaATPase and increase calpain activities. Remarkably, spinal cord tissue from mice treated daily with 2-BFI during the progression of EAE significantly restored B-CK and CaATPase enzymatic activities and showed no induction in calpain activity. Moreover, EAE spinal cord from 2-BFI treated mice also demonstrated better preservation of myelin; reduced axonal injury, as evidenced by the lower level of β-APP expression, and above all, highly improved neurobehavioral scores (p<0.01; n=10). These findings suggest that 2-BFI can be further developed as a therapeutic drug for MS treatment., (Crown Copyright © 2011. Published by Elsevier Inc. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
21. CpG oligodeoxynucleotides protect against the 2009 H1N1 pandemic influenza virus infection in a murine model.
- Author
-
Jiang T, Zhao H, Li XF, Deng YQ, Liu J, Xu LJ, Han JF, Cao RY, Qin ED, and Qin CF
- Subjects
- Animals, Disease Models, Animal, Lung pathology, Lung virology, Mice, Mice, Inbred BALB C, Orthomyxoviridae Infections mortality, Orthomyxoviridae Infections pathology, Orthomyxoviridae Infections virology, Survival Analysis, Viral Load, Immunologic Factors administration & dosage, Influenza A Virus, H1N1 Subtype drug effects, Influenza A Virus, H1N1 Subtype pathogenicity, Oligodeoxyribonucleotides administration & dosage, Orthomyxoviridae Infections prevention & control
- Abstract
The 2009 H1N1 influenza virus pandemic poses a global public health threat, and there is a critical need for antiviral drugs for pandemic control. CpG oligodeoxynucleotides have strong immunostimulatory properties and are expected to be used as prophylactic agents to protect against microbial infections. The present study evaluated the efficacy of synthetic CpG oligodeoxynucleotide (ODN) 1826 against pandemic H1N1 virus infection in a murine model. A single injection of 15 μg ODN 1826 intraperitoneally prior to virus challenge inhibits virus replication in lungs, reduces lung lesions and prevents mortality in mice, indicating CpG ODNs as a possible strategy for future influenza pandemics control., (Copyright © 2010 Elsevier B.V. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
22. Mosaic ring chromosome 18, ring chromosome 18 duplication/deletion and disomy 18: perinatal findings and molecular cytogenetic characterization by fluorescence in situ hybridization and array comparative genomic hybridization.
- Author
-
Chen CP, Kuo YT, Lin SP, Su YN, Chen YJ, Hsueh RY, Lin YH, Wu PC, Lee CC, Chen YT, and Wang W
- Subjects
- Abnormalities, Multiple diagnosis, Adult, Amniocentesis, Chromosome Deletion, Chromosome Disorders genetics, Chromosomes, Human, Pair 18 genetics, Female, Humans, Male, Pregnancy, Uniparental Disomy, Abnormalities, Multiple genetics, Comparative Genomic Hybridization, In Situ Hybridization, Fluorescence, Mosaicism
- Abstract
Objective: To present the perinatal findings and molecular cytogenetic analysis of a rare chromosomal abnormality involving structural and numerical abnormalities of chromosome 18., Materials, Methods and Results: A 36-year-old woman, gravida 5, para 3, underwent amniocentesis because of her advanced maternal age. Amniocentesis revealed a karyotype of 46,XY,r(18) [27]/45,XY,-18[5]/46,XY[5]. The parents decided to continue the pregnancy. Level II ultrasound revealed ventriculomegaly. At 38 weeks of gestation, a 3,725 g male fetus was delivered. The fetus had microcephaly, hypertelorism, epicanthal folds, cleft palate, a broad flat nose, simian creases, broad hands, tapered fingers, clubfeet, micropenis, a sacral dimple, hypotonia, ventriculomegaly, and a ventricular septal defect. The peripheral blood lymphocytes revealed a karyotype of 46,XY,r(18)[81]/45,XY,-18[3]/46,XY,idic r(18)[3]/46,XY[13]. Fluorescence in situ hybridization using chromosome 18 centromeric probe (cep18) and subtelomeric (18pter, 18qter) identified four types of cells, r(18), idic r(18), monosomy 18, and disomy 18. Array comparative genomic hybridization analysis of the blood demonstrated a 14.9-Mb deletion at chromosome 18p [arr cgh 18p11.32p11.21 (0-14,941,330)× 1] and a 29.6-Mb deletion at chromosome 18q [arr cgh 18q21.2q23 (46,533,430-76,117,153) × 1]. The proband's karyotype was 46,XY,r(18)(p11.21q21.2)[81]/45,XY,-18[3]/46,XY,idic r(18)(p11.21q21.2;p11.21q21.2)[3]/46,XY[13]., Conclusion: Array comparative genomic hybridization is useful to determine the breakpoints of a ring chromosome, particularly in cases where the ring chromosome comprises the majority of the mosaicism., (Copyright © 2010 Taiwan Association of Obstetric & Gynecology. Published by Elsevier B.V. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
23. Neonatal endotoxin exposure suppresses experimental autoimmune encephalomyelitis through regulating the immune cells responsivity in the central nervous system of adult rats.
- Author
-
Li XL, Lv J, Xi NN, Wang T, Shang XF, Xu HQ, Han Z, O'Byrne KT, Li XF, and Zheng RY
- Subjects
- Animals, Animals, Newborn, Astrocytes immunology, Down-Regulation, Female, Guinea Pigs, Interferon-gamma antagonists & inhibitors, Interferon-gamma metabolism, Interleukin-10 metabolism, Interleukin-17 antagonists & inhibitors, Interleukin-17 metabolism, Male, Microglia immunology, Rats, Rats, Sprague-Dawley, Up-Regulation, Central Nervous System immunology, Encephalomyelitis, Autoimmune, Experimental immunology, Lipopolysaccharides immunology
- Abstract
Early-life exposure to bacterial endotoxin (lipopolysaccharide, LPS) affects the susceptibility to a variety of systemic organic inflammation in adulthood. To determine the long-term effects of neonatal LPS exposure on inflammatory responses in the central nervous system (CNS) in adulthood, we examined the effects on the development of experimental autoimmune encephalomyelitis (EAE) in adult rats as well as the potential regulatory immune mechanisms involved. The results showed that neonatal LPS exposure significantly reduced the morbidity (p<0.01) and severity (p<0.05) of EAE in adult rats, and decreased inflammatory cell infiltration and demyelination in the CNS compared with neonatal saline controls (p<0.05). Neonatal LPS-treated animals showed reduced activation of microglia and astrocytes, as detected by immunocytochemistry, accompanied by down-regulation of the pro-inflammatory cytokines interleukin-17 and interferon-gamma but up-regulation of anti-inflammatory cytokine interleukin-10 in the CNS (p<0.05). At the same time, cerebrum mRNA levels of the transcription factors T-bet and RORgammat were lower in neonatal LPS-compared with saline- treated animals (p<0.05) accompanied with increased STAT-6 and Foxp3 levels in the neonatal LPS-treated group (p<0.05). These findings suggest that early-life exposure to LPS could provide an important neuroprotective effect on the development of EAE in adult rats due to modulation of inflammatory responses in the CNS., (Copyright (c) 2010 Elsevier Inc. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
24. Methylenetetrahydrofolate reductase polymorphisms and plasma homocysteine in levodopa-treated and non-treated Parkinson's disease patients.
- Author
-
Yuan RY, Sheu JJ, Yu JM, Hu CJ, Tseng IJ, Ho CS, Yeh CY, Hung YL, and Chiang TR
- Subjects
- Age Distribution, Aged, Aged, 80 and over, Amino Acid Substitution genetics, Antiparkinson Agents pharmacology, Antiparkinson Agents therapeutic use, Base Sequence genetics, Biomarkers analysis, Biomarkers blood, DNA Mutational Analysis, Female, Gene Frequency genetics, Genetic Markers genetics, Genetic Testing, Genotype, Humans, Levodopa pharmacology, Levodopa therapeutic use, Male, Parkinson Disease drug therapy, Sex Distribution, Genetic Predisposition to Disease genetics, Homocysteine blood, Methylenetetrahydrofolate Dehydrogenase (NAD+) genetics, Parkinson Disease blood, Parkinson Disease genetics, Polymorphism, Genetic genetics
- Abstract
Genetic C677T and A1298C polymorphisms in 5,10-methylenetetrahydrofolate reductase (MTHFR) and levodopa therapy in Parkinson's disease (PD) may increase homocysteine (Hcy) level. We examined whether connecting both polymorphisms influences the effect of levodopa on Hcy. MTHFR genotypes and Hcy, vitamin B(12), and folate levels were determined in 48 levodopa-treated PD patients (PD-L), 28 non-treated PD patients (PD-N) and 110 controls. Hcy was remarkably higher in PD-L than in PD-N and controls (p<0.001); similarly, the differences were seen in different age subgroups and in both genders. Furthermore, Hcy differences between PD-L and PD-N were evident in 677C/T, T/T, C/T + A/A, T/T + A/A (all p<0.05), and 1298A/A (p<0.001), but not in others such as 677C/C, and C/C + A/A. Hcy in PD-N and controls was comparable for all genotypes. In PD-L, Hcy was the highest in 677T/T, then in C/T, and in C/C with a significant difference from T/T (p=0.014), but was not different among A1298C genotypes. Likewise, Hcy was the highest in 677T/T+1298A/A, intermediate in C/T+A/A, and the lowest in C/C+A/A. In PD-N, Hcy was similar among all genotypes. In conclusion, Hcy elevation may be caused by levodopa administration, and further promoted by 677C/T and T/T, but not by A1298C genotypes. The promoting elevation in 1298A/A is attributed to combining the 677T allele. Neither C677T nor A1298C genotypes contribute to elevating Hcy in PD-N.
- Published
- 2009
- Full Text
- View/download PDF
25. bFGF expression mediated by a hypoxia-regulated adenoviral vector protects PC12 cell death induced by serum deprivation.
- Author
-
Hu HW, Li XK, Zheng RY, Xiao J, Zeng JQ, and Hou ST
- Subjects
- Adenoviridae, Animals, Apoptosis, Cell Hypoxia genetics, Cytomegalovirus, Fibroblast Growth Factor 2 genetics, Humans, PC12 Cells, Rats, Response Elements, Cytoprotection genetics, Fibroblast Growth Factor 2 biosynthesis, Gene Expression Regulation, Genetic Vectors, Neurons metabolism
- Abstract
Basic fibroblast growth factor (bFGF) is a known neuroprotectant against a number of brain injury conditions such as cerebral ischemia. However, bFGF also regulates a plethora of brain developmental processes and functions as a strong mitogen. Therefore, unregulated long-term expression of bFGF in brain may potentially be tumorigenic, limiting its utility in brain therapy. Here, we report the successful construction of an adenoviral vector (Ad-5HRE-bFGF) expressing bFGF under the regulation of five hypoxia-responsive elements (5HRE) and a minimal cytomegalovirus promoter (CMVmp). Following hypoxia treatment in a hypoxic chamber with less than 1% of oxygen, Ad-5HRE-bFGF induced a significant and time-dependent expression of bFGF protein and the fluorescent tag, humanized GFP (hrGFP) protein, in infected PC12 cells. In contrast, normoxia treatment evoked extremely low level of bFGF and hrGFP expression, demonstrating that the 5HRE-CMVmp cassette was effective in regulating the expression of bFGF gene in response to hypoxia. More importantly, bFGF expressed by the Ad-5HRE-bFGF viral vector under the regulation of hypoxia was significantly neuroprotective against PC12 cell death evoked by serum deprivation. Taken together, these studies demonstrated the feasibility to express bFGF in a hypoxia-regulated fashion to provide neuroprotection. The Ad-5HRE-bFGF can be further developed as an effective tool to provide neuroprotection against hypoxia-induced brain diseases, such as cerebral ischemia.
- Published
- 2009
- Full Text
- View/download PDF
26. Predictors for outcome and treatment delay in patients with tuberculous meningitis.
- Author
-
Sheu JJ, Yuan RY, and Yang CC
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Antitubercular Agents therapeutic use, Female, Humans, Male, Middle Aged, Time Factors, Treatment Outcome, Tuberculosis, Meningeal cerebrospinal fluid, Tuberculosis, Meningeal drug therapy
- Abstract
Background: Tuberculous meningitis (TBM) is a challenge for clinicians because of the difficulty in making an early diagnosis and the severe consequences of delaying treatment. The objective of this study was to assess predictors of outcome and to evaluate factors critical to treatment delay of TBM., Methods: One hundred and five adult patients with TBM, between 1997 and 2006, were retrospectively studied. Treatment delay was defined as progression of stage and physician delay between the initial presentation and the start of antituberculosis therapy. Factors contributing to the outcome, progression of stage, and prolonged physician delay were evaluated using univariate and multivariate analyses., Results: Fifty patients (47.6%) experienced prolonged physician delay, and 38 (36.2%) had progression of stage. Thirty-four patients (32.4%) had an acute clinical course, and 76 (72.4%) received initial antibacterial therapy. Prolonged physician delay and progression of stage were important prognostic factors for poor outcome. Stage I at admission and prolonged physician delay were important factors contributing to progression of stage. An acute clinical course and an initial antibacterial therapy were important factors contributing to prolonged physician delay., Conclusions: Rapid diagnosis and early treatment before the occurrence of progression of stage are crucial for the outcome of TBM. TBM may present with an acute course, and when discrimination from bacterial meningitis is difficult, it is mandatory to start antituberculosis and antibacterial therapy simultaneously or lower the threshold for early antituberculosis therapy when persistent fever, deteriorated consciousness status, or progression of stage occurs during antibacterial therapy.
- Published
- 2009
- Full Text
- View/download PDF
27. The epigenetic effects of amyloid-beta(1-40) on global DNA and neprilysin genes in murine cerebral endothelial cells.
- Author
-
Chen KL, Wang SS, Yang YY, Yuan RY, Chen RM, and Hu CJ
- Subjects
- Amyloid beta-Peptides pharmacology, Animals, Cells, Cultured, DNA drug effects, DNA genetics, DNA metabolism, Endothelial Cells enzymology, Mice, Peptide Fragments pharmacology, Promoter Regions, Genetic, Protein Biosynthesis drug effects, RNA, Messenger antagonists & inhibitors, RNA, Messenger biosynthesis, Amyloid beta-Peptides metabolism, Cerebral Cortex enzymology, DNA Methylation, Epigenesis, Genetic, Gene Expression Regulation, Enzymologic, Neprilysin genetics, Peptide Fragments metabolism
- Abstract
Amyloid-beta (Abeta) is the core component of senile plaques, which are the pathological markers for Alzheimer's disease and cerebral amyloid angiopathy. DNA methylation/demethylation plays a crucial role in gene regulation and could also be responsible for presentation of senescence. Oxidative stress, which may be induced by Abeta, is thought to be an important contributor of DNA hyper-methylation; however, contradicting this is the fact that global DNA hypo-methylation has been found in aging brains. It therefore remains largely unknown as to whether Abeta does in fact cause DNA methylation/demethylation. Neprilysin (NEP) is one of the enzymes responsible for Abeta degradation, with its expression decreasing in both Alzheimer and aging brains. Using high-performance liquid chromatography (HPLC), we explore whether Abeta is responsible for alteration of the global DNA methylation status on a murine cerebral endothelial cells model, and also use methylation-specific PCR (MSPCR) to examine whether DNA methylation status is altered on the NEP promoter region. We find that Abeta reduces global DNA methylation whilst increasing NEP DNA methylation and further suppressing the NEP expression in mRNA and protein levels. Our results support that Abeta induces epigenetic effects, implying that DNA methylation may be part of a vicious cycle involving the reduction in NEP expression along with a resultant increase in Abeta accumulation, and that Abeta may induce global DNA hypo-methylation.
- Published
- 2009
- Full Text
- View/download PDF
28. Temporal changes in the expression of TGF-beta 1 and EGF in the ventral horn of the spinal cord and associated precentral gyrus in adult Rhesus monkeys subjected to cord hemisection.
- Author
-
Li XL, Liu J, Wang XY, Li LY, Ni W, Zheng RY, Yang HJ, Lu YC, Qi JG, and Wang TH
- Subjects
- Animals, Disease Models, Animal, Epidermal Growth Factor genetics, Functional Laterality, Macaca mulatta, Male, Motor Activity physiology, Recovery of Function physiology, Spinal Cord Injuries mortality, Spinal Cord Injuries physiopathology, Time Factors, Transforming Growth Factor beta1 genetics, Anterior Horn Cells metabolism, Epidermal Growth Factor metabolism, Gene Expression Regulation physiology, Spinal Cord pathology, Spinal Cord Injuries pathology, Transforming Growth Factor beta1 metabolism
- Abstract
It is well known that some growth factors can not only rescue neurons from death, but also improve motor functions following spinal cord injury. However, their cellular distribution in situ and temporal expressions following spinal cord injury have not been determined, especially in primates. This study investigated the temporal changes in the expression of two growth factors--epidermal growth factor (EGF) and transforming growth factor-beta 1 (TGF-beta1) in the injured motoneurons of the spinal cord and the associated precentral gyrus in adult Rhesus monkeys subjected to spinal cord hemisection. Animals were allowed to survive 7, 14, 30 and 90 days post operation (dpo). Functional recovery of the hindlimbs was assessed using Tarlov scale. The immunohistological expressions of EGF and TGF-beta1 in the ventral horn motoneurons decreased sharply at 7 dpo in the cord segments caudal to the lesion site, which was followed by an increase and a peak between 14 and 30 dpo for EGF and at 90 dpo for TGF-beta1. Changes in the expression of EGF in the precentral gyrus were similar to that in the spinal cord. No TGF-beta1 immunoreactive neurons were detected in the precentral gyrus. In the spinal segments rostral to the lesion, the expressions of EGF and TGF-beta1 peaked at 30 dpo. The mRNA of EGF was detected in both spinal motoneurons and the precentral gyrus, while that of TGF-beta1, only in the spinal motoneuons, suggesting that the spinal motoneurons themselves could synthesize both the growth factors. Partial locomotor recovery in hindlimbs was seen, especially after 14 dpo. It was concluded that a possible association existed between the modulation of EGF and TGF-beta1 and the recovery of locomotor function, and their roles differed somewhat in the neuroplasticity observed after spinal cord injury in primates.
- Published
- 2008
- Full Text
- View/download PDF
29. Segmental study of the median nerve versus comparative tests in the diagnosis of mild carpal tunnel syndrome.
- Author
-
Sheu JJ, Yuan RY, Chiou HY, Hu CJ, and Chen WT
- Subjects
- Adult, Aged, Diagnostic Techniques, Neurological, Early Diagnosis, Female, Humans, Male, Middle Aged, Prospective Studies, Reaction Time, Sensitivity and Specificity, Severity of Illness Index, Ulnar Nerve physiopathology, Carpal Tunnel Syndrome diagnosis, Carpal Tunnel Syndrome physiopathology, Electrodiagnosis methods, Median Nerve physiopathology, Neural Conduction
- Abstract
Objective: The aims of this study were to analyze normative data of nerve conduction studies (NCS) by optimal transformations, and compare the utility of electrodiagnostic tests in detecting mild carpal tunnel syndrome (CTS)., Methods: In 131 hands of patients with mild CTS and 136 hands of controls, the segmental study of the median nerve between the digit-palm and palm-wrist segments, and the median-to-ulnar and median-to-radial comparative tests were performed. Normal limits were derived by calculating the mean+/-2 standard deviations of the optimally transformed data of the controls. The specificity, sensitivity, and misclassification rate were calculated to evaluate the utility of each test., Results: All tests had high specificities, ranging from 98.5 to 100%. The distoproximal latency ratio (DPLR) of the median nerve showed the highest sensitivity and the difference between the median and radial sensory latencies (D1M-D1R) the second highest, but there was no statistical difference between them. The difference between the median and ulnar mixed nerve latencies in the palm-to-wrist segment (PM-PU) showed the lowest sensitivity. Misclassification rates of the DPLR, D1M-D1R, and PM-PU were 6.9, 3.8, and 6.1%, respectively., Conclusions: Optimal transformation of NCS data is mandatory to diminish the effect of skewness and enhance the diagnostic accuracy. As compared to the comparative tests, the segmental study of the median nerve is more easily applied and yields higher sensitivity in detecting mild CTS., Significance: With a high diagnostic yield and easy application, the segmental study of the median nerve may routinely be used to evaluate patients with mild CTS.
- Published
- 2006
- Full Text
- View/download PDF
30. Nucleophosmin-anaplastic lymphoma kinase of anaplastic large-cell lymphoma recruits, activates, and uses pp60c-src to mediate its mitogenicity.
- Author
-
Cussac D, Greenland C, Roche S, Bai RY, Duyster J, Morris SW, Delsol G, Allouche M, and Payrastre B
- Subjects
- Anaplastic Lymphoma Kinase, Animals, Blood Proteins metabolism, Blood Proteins pharmacology, Cell Division, Chromosomes, Human, Pair 2, Chromosomes, Human, Pair 5, Humans, Jurkat Cells, Nuclear Proteins genetics, Nucleoplasmins, Phosphoproteins genetics, Phosphorylation, Protein-Tyrosine Kinases genetics, Receptor Protein-Tyrosine Kinases, Translocation, Genetic, Tyrosine metabolism, Lymphoma, Large B-Cell, Diffuse genetics, Lymphoma, Large B-Cell, Diffuse metabolism, Nuclear Proteins metabolism, Phosphoproteins metabolism, Protein-Tyrosine Kinases metabolism, Proto-Oncogene Proteins pp60(c-src) metabolism
- Abstract
Anaplastic large-cell lymphomas (ALCLs) are lymphomas of T or null phenotype often associated with a chromosomal translocation, t(2;5)(p23;q35). This translocation leads to the expression of a hybrid protein consisting of the N-terminal portion of nucleophosmin (NPM) and the intracellular domain of the anaplastic lymphoma kinase (ALK). NPM-ALK possesses a constitutive tyrosine kinase activity responsible for its oncogenic property through activation of downstream effectors such as phospholipase C gamma (PLC-gamma) and the type IA phosphoinositide 3-kinase. Here, we show that the Src-kinases, particularly pp60(c-src), associate with and are activated by NPM-ALK expression in various cells, and in cell lines established from patients with ALCL. The kinase activity and the tyrosine 418 of NPM-ALK are required for its association with Src-kinases. Y418F mutation of NPM-ALK impaired its association with Src-kinases and strongly reduced the proliferation rate of Ba/F3 cells. In agreement, Src-kinase inhibitors or pp60(c-src) siRNA significantly decreased the proliferation rate of NPM-ALK-positive ALCL cell lines. Moreover, using active or inactive forms of pp60(c-src) and NPM-ALK, we provide evidence that NPM-ALK is a potential substrate of pp60(c-src). Overall, our data place Src-kinases as new important downstream effectors of NPM-ALK and as attractive potential therapeutic targets for new ALCL treatment.
- Published
- 2004
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.